Track the Gubra A/S share price and the full insider trade history of the company, a listed equity based in Denmark. Shares are quoted on the DK market, under the authority of Finanstilsynet DK. Operating in the Healthcare & Pharma sector, Gubra A/S has recorded 34 reports. Market capitalisation: €5.8bn. The latest transaction was disclosed on 17 June 2026 (Other). The full history is openly available.
34
Insider Decl.
n/a
Thresholds
€4m
13 ops.
Buy Volume
€25m
4 ops.
Sell Volume
35Σ signal
Buys €4m€25m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 353 of 28,958 companies
86.5
score / 100
Value
97
Quality
76
FCF yld26%
Earn yld26%
EV/EBITDA3.0x
ROE-16%
Gross mgn97%
Net mgn64%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
20,189 shares0ShareOutside a trading venueISINISIN DK0062266474DK:1231786
25 of 34 declarations
About Gubra A/S
Gubra A/S is a Danish company focused on research and development of treatments for metabolic diseases. It emphasizes innovation in the healthcare and pharmaceutical sectors.